Senthil Chinnakannan

Molecular virologist/vaccinologist at the University of Oxford, passionate about translational research. Interests: Adeno/MVA viral vectors, therapeutic hepatitis B vaccine, prophylactic hepatitis C vaccine, therapeutic cancer vaccine

Speciality Vaccinologist
Degrees PhD in Molecular Virology, Master in Animal Biotechnology (M.V.Sc), Bachelors in Veterinary Medicine (B.V.Sc)
Areas of Expertise
  • Molecular Biology
  • Adenoviral and MVA viral vectored vaccine development
  • Immunology


After completing a PhD in molecular virology at the Pirbright Institute, Senthil moved to the Nuffield Department of Medicine, University of Oxford in May 2012. Since then he has been working on Adenoviral and MVA viral vectored vaccine platform. Initially, he worked in Prof. Sarah Gilbert’s group, at the Jenner Institute, on Chimp-Adeno and MVA viral vector modifications and the flu vaccine development program and then moved to Prof. Ellie Barnes group at Peter Medawar Building (PMB). In association with Prof. Ellie Barnes, Prof. Paul Klenerman, Dr Lian Lee and Dr Jonathan Kwok at the Peter Medawar building, Senthil currently works on the translational research programs involving the design and development of viral vectored vaccines for hepatitis B, hepatitis C and cancer.

Key Accomplishments

Postdoctoral ScientistUniversity of Oxford

Venture ScientistConception X

Senior Research ScientistPiramal Enterprises Limited